Loading clinical trials...
Loading clinical trials...
Lung neoplasms are characterized by a complex interaction between tumor cells and a variety of resident and infiltrating host elements, secreted factors, and extracellular matrix proteins, collectively referred to as the microenvironment. Nowadays, in the setting of lung cancer, and in particular non-small cell lung cancer (NSCLC), the evaluation of microenvironment characteristics can only be performed by a pathologist and only on histological material. By combining different MRI parameters, it may be possible to create a specific imaging "signature" for the three different immune phenotypes and thus be able to make a distinction based on MRI examination.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Fondazione IRCCS Policlinico San Matteo
Pavia, Italy
Start Date
January 15, 2020
Primary Completion Date
April 1, 2026
Completion Date
April 1, 2026
Last Updated
March 20, 2026
50
ESTIMATED participants
Lead Sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia
NCT06305754
NCT06987890
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions